The standard contains eight quality statements that describe the health care you should receive to support the correct use of psychotropic medicines. This fact sheet explains each quality statement and what it means for you.  

This issue includes items on mental health, stroke, governance, communication, nursing, and more. Also covered are the latest from BMJ Quality & Safety, Australian Journal of Primary Health, Health Affairs, Health Policy, International Journal for Quality in Health Care and the UK’s NICE and the USA’s AHRQ.

This issue includes items on the new Australian Safety and Quality Medical Imaging Accreditation Scheme, digital health literacy, performance, mental health, gaming and e-sports, health technology assessment, older patients, transitions of care, rheumatoid arthritis, and more. Along with the latest from BMJ Quality & Safety, Australian...

The Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard contains eight quality statements and seven indicators to ensure the safe and appropriate use of psychotropic medicines in people with cognitive disability or impairment and uphold their rights, dignity, health and quality of life.

This resource lists the eight quality statements in the clinical care standard that aim to ensure the safe and appropriate use of psychotropic medicines in people with cognitive disability or impairment.